[Skip to Navigation]
Sign In
Comment & Response
January 1, 2014

Combination Pill for Cardiovascular Disease

Author Affiliations
  • 1Family Medicine Pharmacy Residency Program, ProMedica Toledo Hospital, Toledo, Ohio
JAMA. 2014;311(1):93. doi:10.1001/jama.2013.283133

To the Editor Dr Thom and colleagues1 addressed medication adherence by analyzing the effects of an FDC pill for patients with or at high risk of cardiovascular disease. Thom et al1 assessed participants at 6-month intervals for a minimum of 12 months up to a maximum of 24 months from the initial intervention.

Add or change institution